Pharma major Cipla on Wednesday said its arm Cipla (EU) Ltd has signed an agreement with CitiHealth Imports to acquire remaining 40 per cent stake in Cipla Pharma Lanka. Cipla (EU) Ltd already has a 60 per cent stake in Cipla Pharma Lanka Pvt Ltd. Post-acquisition, Cipla Pharma Lanka will become a wholly-owned subsidiary, Cipla said in a filing to the BSE. The acquisition of 40 per cent stake is for a cash consideration of LKR 400,000 (over Rs 1.5 lakh) to be paid on closing of transaction, it added. "The transaction is expected to be completed before December 10, 2019," the filing said. Cipla Pharma Lanka is a private limited liability company incorporated in Sri Lanka on August 8, 2014 having a market share of 6.5 per cent in Sri Lankan market, it added. The company was formed as a joint venture between Cipla (EU) and CitiHealth Imports Pvt Ltd to conduct marketing and distribution of pharmaceutical products, Cipla said. Shares of Cipla Ltd on Wednesday closed 2.21 per cent lower at Rs 467.75 per scrip on the BSE.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!